TY  - GEN
AU  - Matsoukas,John
AU  - Apostolopoulos,Vasso
AU  - Matsoukas,John
AU  - Apostolopoulos,Vasso
TI  - Advances in Multiple Sclerosis Research-Series I
SN  - books978-3-03943-948-5
PY  - 2021///
CY  - Basel, Switzerland
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Medicine
KW  - bicssc
KW  - multiple sclerosis
KW  - inflammation
KW  - oxidative
KW  - biomarker
KW  - sample size
KW  - autoimmune encephalitis
KW  - plasma exchange
KW  - autoimmunity
KW  - immunotherapeutics
KW  - clinical outcomes
KW  - major depression
KW  - bupropion
KW  - S-adenosylmethionine
KW  - vitamin D3
KW  - yoga
KW  - craniopharyngioma
KW  - fractionated stereotactic radiation treatments
KW  - sphenoid sinusitis
KW  - cranial nerve-VI palsy
KW  - autoimmune diseases
KW  - immune thrombocytopenic purpura
KW  - alemtuzumab
KW  - antibodies against GluR3 peptide
KW  - cognitive impairment
KW  - diagnosis
KW  - neuropsychological assessment
KW  - short intracortical inhibition
KW  - intracortical facilitation
KW  - fampridine
KW  - walking disability
KW  - TSPAN32
KW  - tetraspanins
KW  - cellular immunity
KW  - memory T cells
KW  - tDCS
KW  - neuroimaging
KW  - positron emission tomography
KW  - cerebral blood flow
KW  - probiotics
KW  - Streptococcus thermophilus
KW  - ST285
KW  - MBP83-99 peptide
KW  - mannan
KW  - immune modulation
KW  - agonist peptide
KW  - gut microbiome
KW  - gut-brain axis
KW  - metagenomics
KW  - disease-modifying treatments
KW  - MS
KW  - vaccine
KW  - immunomodulation
KW  - carriers
KW  - B cell receptor
KW  - delivery methods
KW  - immunotherapy
KW  - monoclonal antibodies
KW  - T cell receptor
KW  - tolerance
KW  - diagnostic markers
KW  - immunoglobulins
KW  - kappa
KW  - free light chains
KW  - antigen-specific immunotherapies
KW  - tolerogenic vaccines
KW  - tolerance induction
KW  - central nervous system
KW  - myelin peptides
KW  - myelin basic protei
KW  - proteolipid protein
KW  - myelin oligodendrocyte glycoprotein
KW  - nanotechnology
KW  - drug delivery nanosystems
KW  - lipids
KW  - polymers
KW  - vaccines
KW  - nanoparticles
KW  - antigen-specific immunotherapy
KW  - experimental autoimmune encephalomyelitis
KW  - neurodegeneration
KW  - chloroquine
KW  - EAE
KW  - dendritic cells
KW  - microglia
KW  - astrocytes
KW  - oligodendrocytes
KW  - conformational analysis
KW  - peptides
KW  - altered peptide ligands
KW  - NMR spectroscopy
KW  - NOE-constraints
KW  - molecular dynamic
KW  - trimolecular complex
KW  - Multiple Sclerosis
KW  - early-onset
KW  - adult-onset
KW  - Human Leucocyte Antigens
KW  - immunogenetics
KW  - clinical phenotype
KW  - clinical outcome
KW  - therapeutics
KW  - antibody detection
KW  - ELISA
KW  - multivalency
KW  - N-glucosylated peptide epitopes
KW  - peptide
KW  - conjugation
KW  - MOG35-55
KW  - Graphite/SiO2 electrode
KW  - voltammetry
KW  - HPLC
KW  - MS drugs
N1  - Open Access
N2  - Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials
UR  - https://mdpi.com/books/pdfview/book/3604
UR  - https://directory.doabooks.org/handle/20.500.12854/68583
ER  -